股市必读：奇正藏药（002287）10月15日董秘有最新回复

Core Viewpoint - The company, Qizheng Tibetan Medicine, is experiencing stable stock performance despite external economic uncertainties, with minimal impact on production costs and profits due to its limited exposure to U.S. imports [1]. Company Performance - As of October 15, 2025, Qizheng Tibetan Medicine's stock closed at 26.73 yuan, reflecting a 0.3% increase with a turnover rate of 0.8% and a trading volume of 45,900 shares, resulting in a transaction value of 1.22 billion yuan [1]. - The company reported that foreign business revenue accounted for only 0.05% of total revenue in the first half of 2025, indicating that changes in U.S. policies will have a negligible effect on overall income [1]. Market Sentiment - On October 15, 2025, the net inflow of main funds into the stock was 7.38 million yuan, while speculative funds also saw a net inflow of 7.24 million yuan, suggesting a positive market sentiment towards the stock [1]. - Retail investors, however, showed a net outflow of 14.63 million yuan, indicating a divergence in investment behavior among different investor classes [1].